*Percentage of participants with neutralizing antibody titers above the threshold of ≥150 determined by μPRNT50 titer.
†Success criterion: lower bound of the 95% CI for SRR >70%.
‡Clinical significance unknown.
SRR:seroresponse rate; CI: confidence interval; μPRNT: micro plaque reduction neutralization test.